{"id":"https://openalex.org/W2559562829","doi":"https://doi.org/10.1016/s1470-2045(16)30558-7","title":"Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study","display_name":"Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study","publication_year":2016,"publication_date":"2016-12-01","ids":{"openalex":"https://openalex.org/W2559562829","doi":"https://doi.org/10.1016/s1470-2045(16)30558-7","mag":"2559562829","pmid":"https://pubmed.ncbi.nlm.nih.gov/27916398"},"language":"en","primary_location":{"id":"doi:10.1016/s1470-2045(16)30558-7","doi":"https://doi.org/10.1016/s1470-2045(16)30558-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1470-2045(16)30558-7","pdf_url":null,"source":{"id":"https://openalex.org/S116900674","display_name":"The Lancet Oncology","issn_l":"1470-2045","issn":["1470-2045","1474-5488"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009381933","display_name":"Francesco Passamonti","orcid":"https://orcid.org/0000-0001-8068-5289","observed_orcids":["https://orcid.org/0000-0001-8068-5289"]},"institutions":[{"id":"https://openalex.org/I115752224","display_name":"University of Insubria","ror":"https://ror.org/00s409261","country_code":"IT","type":"education","lineage":["https://openalex.org/I115752224"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Francesco Passamonti","raw_affiliation_strings":["Department of Hematology, University of Insubria, Varese, Italy. Electronic address: francesco.passamonti@asst-settelaghi.it","Department of Hematology, University of Insubria, Varese, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, University of Insubria, Varese, Italy. Electronic address: francesco.passamonti@asst-settelaghi.it","institution_ids":["https://openalex.org/I115752224"]},{"raw_affiliation_string":"Department of Hematology, University of Insubria, Varese, Italy","institution_ids":["https://openalex.org/I115752224"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006360930","display_name":"Martin Grie\u00dfhammer","orcid":"https://orcid.org/0000-0001-8718-7004","observed_orcids":["https://orcid.org/0000-0001-8718-7004"]},"institutions":[{"id":"https://openalex.org/I4210162969","display_name":"Johannes Wesling Klinikum Minden","ror":"https://ror.org/05d89kr76","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799784675","https://openalex.org/I4210162969"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Martin Griesshammer","raw_affiliation_strings":["Department of Hematology, Oncology, Hemostaseology and Palliative Care, Johannes Wesling Clinic, Minden, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Oncology, Hemostaseology and Palliative Care, Johannes Wesling Clinic, Minden, Germany","institution_ids":["https://openalex.org/I4210162969"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002133396","display_name":"Francesca Palandri","orcid":"https://orcid.org/0000-0001-8367-5668","observed_orcids":["https://orcid.org/0000-0001-8367-5668"]},"institutions":[{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesca Palandri","raw_affiliation_strings":["Department of Hematology/Oncology, Ser\u00e0gnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology/Oncology, Ser\u00e0gnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy","institution_ids":["https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029935496","display_name":"Mikl\u00f3s Egyed","orcid":"https://orcid.org/0000-0002-5513-5880","observed_orcids":["https://orcid.org/0000-0002-5513-5880"]},"institutions":[{"id":"https://openalex.org/I4210099897","display_name":"Somogy Megyei Kaposi M\u00f3r Oktat\u00f3 K\u00f3rh\u00e1z","ror":"https://ror.org/015mptv94","country_code":"HU","type":"healthcare","lineage":["https://openalex.org/I4210099897"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Miklos Egyed","raw_affiliation_strings":["Hematology Department of Somogy County, Kaposi Mor Teaching Hospital, Kaposvar, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Department of Somogy County, Kaposi Mor Teaching Hospital, Kaposvar, Hungary","institution_ids":["https://openalex.org/I4210099897"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026430732","display_name":"Giulia Benevolo","orcid":"https://orcid.org/0000-0002-3200-9654","observed_orcids":["https://orcid.org/0000-0002-3200-9654"]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giulia Benevolo","raw_affiliation_strings":["Department of Hematology, Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091536542","display_name":"Timothy Devos","orcid":"https://orcid.org/0000-0002-6881-417X","observed_orcids":["https://orcid.org/0000-0002-6881-417X"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Timothy Devos","raw_affiliation_strings":["Laboratory of Experimental Transplantation, Department of Microbiology and Immunology and Department of Hematology, University Hospitals Leuven, KU Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Experimental Transplantation, Department of Microbiology and Immunology and Department of Hematology, University Hospitals Leuven, KU Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108134851","display_name":"Jeannie Callum","orcid":"https://orcid.org/0000-0001-6133-0677","observed_orcids":["https://orcid.org/0000-0001-6133-0677"]},"institutions":[{"id":"https://openalex.org/I1323843004","display_name":"Sunnybrook Health Science Centre","ror":"https://ror.org/03wefcv03","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jeannie Callum","raw_affiliation_strings":["Department of Transfusion Medicine and Tissue Banks, Sunnybrook Health Sciences Centre, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Transfusion Medicine and Tissue Banks, Sunnybrook Health Sciences Centre, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1323843004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046772202","display_name":"Alessandro Maria Vannucchi","orcid":"https://orcid.org/0000-0001-5755-0730","observed_orcids":["https://orcid.org/0000-0001-5755-0730"]},"institutions":[{"id":"https://openalex.org/I45084792","display_name":"University of Florence","ror":"https://ror.org/04jr1s763","country_code":"IT","type":"education","lineage":["https://openalex.org/I45084792"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alessandro M Vannucchi","raw_affiliation_strings":["Department of Experimental and Clinical Medicine, Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, University of Florence, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental and Clinical Medicine, Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, University of Florence, Florence, Italy","institution_ids":["https://openalex.org/I45084792"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038056445","display_name":"Serdar \u015e\u0131vg\u0131n","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I87673952","display_name":"Erciyes University","ror":"https://ror.org/047g8vk19","country_code":"TR","type":"education","lineage":["https://openalex.org/I87673952"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Serdar Sivgin","raw_affiliation_strings":["Department of Hematology, Dedeman Stem Cell Transplantation Hospital, Erciyes University, Kayseri, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Dedeman Stem Cell Transplantation Hospital, Erciyes University, Kayseri, Turkey","institution_ids":["https://openalex.org/I87673952"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015297647","display_name":"Caroline Bensasson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caroline Bensasson","raw_affiliation_strings":["Department of Clinical Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022437253","display_name":"Md Mahmudul Hasan Khan","orcid":"https://orcid.org/0000-0001-8195-3783","observed_orcids":["https://orcid.org/0000-0001-8195-3783"]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mahmudul Khan","raw_affiliation_strings":["Department of Biostatistics, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051885002","display_name":"Nadjat Mounedji","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092929","display_name":"Novartis (France)","ror":"https://ror.org/00geypp27","country_code":"FR","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210092929"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nadjat Mounedji","raw_affiliation_strings":["Department of Oncology, Novartis Pharma S.A.S., Rueil-Malmaison, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Novartis Pharma S.A.S., Rueil-Malmaison, France","institution_ids":["https://openalex.org/I4210092929"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090217849","display_name":"G\u00fcray Saydam","orcid":"https://orcid.org/0000-0001-8646-1673","observed_orcids":["https://orcid.org/0000-0001-8646-1673"]},"institutions":[{"id":"https://openalex.org/I41641357","display_name":"Ege University","ror":"https://ror.org/02eaafc18","country_code":"TR","type":"education","lineage":["https://openalex.org/I41641357"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Guray Saydam","raw_affiliation_strings":["Department of Hematology, Ege University Medical Faculty, Izmir, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Ege University Medical Faculty, Izmir, Turkey","institution_ids":["https://openalex.org/I41641357"]}]}],"institutions":[],"countries_distinct_count":8,"institutions_distinct_count":12,"corresponding_author_ids":["https://openalex.org/A5009381933"],"corresponding_institution_ids":["https://openalex.org/I115752224"],"apc_list":{"value":7280,"currency":"USD","value_usd":7280},"apc_paid":null,"fwci":17.9615,"has_fulltext":false,"cited_by_count":273,"citation_normalized_percentile":{"value":0.99527108,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"18","issue":"1","first_page":"88","last_page":"99"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ruxolitinib","display_name":"ruxolitinib","score":0.9430000185966492},{"id":"https://openalex.org/keywords/polycythemia-vera","display_name":"polycythemia vera","score":0.9990000128746033},{"id":"https://openalex.org/keywords/jak1-2-inhibitor","display_name":"JAK1/2 inhibitor","score":0.7829999923706055},{"id":"https://openalex.org/keywords/hydroxyurea-resistance","display_name":"hydroxyurea resistance","score":0.8500000238418579},{"id":"https://openalex.org/keywords/hydroxyurea-intolerance","display_name":"hydroxyurea intolerance","score":0.9120000004768372},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.8230000138282776},{"id":"https://openalex.org/keywords/best-available-therapy","display_name":"best available therapy","score":0.6579999923706055},{"id":"https://openalex.org/keywords/interferon","display_name":"interferon","score":0.4869999885559082},{"id":"https://openalex.org/keywords/pipobroman","display_name":"pipobroman","score":0.7950000166893005},{"id":"https://openalex.org/keywords/anagrelide","display_name":"anagrelide","score":0.9760000109672546},{"id":"https://openalex.org/keywords/immunomodulators","display_name":"immunomodulators","score":0.6179999709129333},{"id":"https://openalex.org/keywords/cytoreductive-therapy","display_name":"cytoreductive therapy","score":0.5249999761581421},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.38600000739097595},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.7329999804496765}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9578465223312378},{"id":"https://openalex.org/C2778740236","wikidata":"https://www.wikidata.org/wiki/Q933716","display_name":"Polycythaemia","level":2,"score":0.9327690601348877},{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.8829463720321655},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.541190505027771},{"id":"https://openalex.org/C2778837598","wikidata":"https://www.wikidata.org/wiki/Q948318","display_name":"Polycythemia vera","level":2,"score":0.5388659238815308},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4338177442550659},{"id":"https://openalex.org/C2781107747","wikidata":"https://www.wikidata.org/wiki/Q1898104","display_name":"Myeloproliferative neoplasm","level":4,"score":0.43148523569107056},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.42259398102760315},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3560420274734497},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.2703440189361572},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011087","descriptor_name":"Polycythemia Vera","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011087","descriptor_name":"Polycythemia Vera","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013163","descriptor_name":"Splenomegaly","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013163","descriptor_name":"Splenomegaly","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016879","descriptor_name":"Salvage Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1016/s1470-2045(16)30558-7","doi":"https://doi.org/10.1016/s1470-2045(16)30558-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1470-2045(16)30558-7","pdf_url":null,"source":{"id":"https://openalex.org/S116900674","display_name":"The Lancet Oncology","issn_l":"1470-2045","issn":["1470-2045","1474-5488"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Oncology","raw_type":"journal-article"},{"id":"pmid:27916398","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27916398","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet. Oncology","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:flore.unifi.it:2158/1084509","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2158/1084509","pdf_url":null,"source":{"id":"https://openalex.org/S4306402033","display_name":"Florence Research (University of Florence)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45084792","host_organization_name":"University of Florence","host_organization_lineage":["https://openalex.org/I45084792"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:irinsubria.uninsubria.it:11383/2061630","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11383/2061630","pdf_url":null,"source":{"id":"https://openalex.org/S4377196351","display_name":"IrInSubria (University of Insubria)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I115752224","host_organization_name":"University of Insubria","host_organization_lineage":["https://openalex.org/I115752224"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320310388","display_name":"Novartis Pharmaceuticals Corporation","ror":"https://ror.org/028fhxy95"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W942930643","https://openalex.org/W1571680356","https://openalex.org/W1964863089","https://openalex.org/W1975006217","https://openalex.org/W1979832242","https://openalex.org/W1980972742","https://openalex.org/W1983958439","https://openalex.org/W1998721150","https://openalex.org/W2009766779","https://openalex.org/W2054753195","https://openalex.org/W2066465348","https://openalex.org/W2072881492","https://openalex.org/W2078504876","https://openalex.org/W2083483941","https://openalex.org/W2094456737","https://openalex.org/W2107398329","https://openalex.org/W2112316414","https://openalex.org/W2114995805","https://openalex.org/W2115351357","https://openalex.org/W2121743767","https://openalex.org/W2122395736","https://openalex.org/W2133633030","https://openalex.org/W2147370660","https://openalex.org/W2149373649","https://openalex.org/W2158669800","https://openalex.org/W2178961707","https://openalex.org/W2199810342","https://openalex.org/W2217750424","https://openalex.org/W2287599500","https://openalex.org/W2290049632","https://openalex.org/W2292715199","https://openalex.org/W2336835135","https://openalex.org/W2339658711","https://openalex.org/W2592960501","https://openalex.org/W4242351610"],"related_works":["https://openalex.org/W1980894889","https://openalex.org/W4280594357","https://openalex.org/W3001373379","https://openalex.org/W2912061124","https://openalex.org/W2757452091","https://openalex.org/W2336835135","https://openalex.org/W3095758083","https://openalex.org/W2326125048","https://openalex.org/W2122395736","https://openalex.org/W2981576356"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":20},{"year":2025,"cited_by_count":20},{"year":2024,"cited_by_count":22},{"year":2023,"cited_by_count":30},{"year":2022,"cited_by_count":20},{"year":2021,"cited_by_count":43},{"year":2020,"cited_by_count":40},{"year":2019,"cited_by_count":26},{"year":2018,"cited_by_count":27},{"year":2017,"cited_by_count":24},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-12-08T00:00:00"}